Clinical Trial Update: A Study to Determine the Safety and Sensitizing Potential of HAT1 Topical Products Using Skin Sensitivity Patch Tests [Phase 4]

View source ↗

Summary

Phase 4 trial assessing safety and sensitizing potential of HAT1 topical products using skin sensitivity patch tests in healthy and atopic dermatitis population…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Healthy Individuals
• Psoriasis

Drugs mentioned

• HAT1 topical products

Snippet

Sponsor: Haus Bioceuticals | Conditions: Healthy, Atopic Dermatitis | Phase 4 | Status: COMPLETED